INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $948,006 | +16.3% | 51,133 | -30.6% | 0.05% | +18.2% |
| Q2 2023 | $814,989 | +26.9% | 73,688 | +54.1% | 0.04% | +10.0% |
| Q1 2023 | $642,330 | +121.5% | 47,828 | +690.4% | 0.04% | +150.0% |
| Q2 2020 | $290,000 | -11.0% | 6,051 | +16.8% | 0.02% | -33.3% |
| Q1 2020 | $326,000 | -64.2% | 5,180 | -29.4% | 0.02% | -40.0% |
| Q4 2019 | $910,000 | +114.1% | 7,341 | +14.5% | 0.04% | +90.5% |
| Q3 2019 | $425,000 | -16.5% | 6,409 | +0.2% | 0.02% | -12.5% |
| Q2 2019 | $509,000 | -25.6% | 6,399 | +4.7% | 0.02% | -27.3% |
| Q1 2019 | $684,000 | +12.3% | 6,114 | +1.1% | 0.03% | -13.2% |
| Q4 2018 | $609,000 | -35.6% | 6,047 | -19.2% | 0.04% | +5.6% |
| Q3 2018 | $946,000 | +73.6% | 7,488 | +15.2% | 0.04% | +63.6% |
| Q2 2018 | $545,000 | +49.3% | 6,499 | +9.4% | 0.02% | +46.7% |
| Q1 2018 | $365,000 | -4.9% | 5,940 | -9.6% | 0.02% | 0.0% |
| Q4 2017 | $384,000 | -10.3% | 6,569 | -11.0% | 0.02% | -16.7% |
| Q3 2017 | $428,000 | -47.9% | 7,382 | +8.7% | 0.02% | -51.4% |
| Q2 2017 | $822,000 | +0.9% | 6,793 | -5.7% | 0.04% | +2.8% |
| Q1 2017 | $815,000 | -3.8% | 7,202 | -7.7% | 0.04% | -7.7% |
| Q4 2016 | $847,000 | -42.9% | 7,800 | -13.4% | 0.04% | -45.1% |
| Q3 2016 | $1,483,000 | +10.0% | 9,009 | -4.6% | 0.07% | +7.6% |
| Q2 2016 | $1,348,000 | +7.8% | 9,446 | -2.9% | 0.07% | +1.5% |
| Q1 2016 | $1,250,000 | -30.9% | 9,730 | -19.7% | 0.06% | -24.4% |
| Q4 2015 | $1,809,000 | -9.5% | 12,113 | +0.5% | 0.09% | -24.6% |
| Q3 2015 | $1,998,000 | -19.1% | 12,048 | +17.7% | 0.11% | +11.8% |
| Q2 2015 | $2,471,000 | -9.5% | 10,236 | +5.7% | 0.10% | -3.8% |
| Q1 2015 | $2,731,000 | +117.1% | 9,685 | +20.1% | 0.11% | +103.8% |
| Q4 2014 | $1,258,000 | -26.0% | 8,062 | +12.3% | 0.05% | -35.0% |
| Q3 2014 | $1,699,000 | – | 7,179 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |